CLDI.WS

Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CLDI.WS was delisted on the 17th of October, 2024.

Back to rankings

1 hedge funds and large institutions have $1.01K invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
1
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$30.2K
2
-$20.7K
3
-$9.3K
4
FC
Finepoint Capital
Massachusetts
-$8.58K
5
6CM
683 Capital Management
New York
-$7.86K
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
1
Exos Asset Management
New York
$1.01K
PAMP
2
Polar Asset Management Partners
Ontario, Canada
–
DCM
3
Driehaus Capital Management
Illinois
–
FC
4
Finepoint Capital
Massachusetts
–
6CM
5
683 Capital Management
New York
–
AC
6
Aristeia Capital
Connecticut
–
Nomura Holdings
7
Nomura Holdings
Japan
–
SCM
8
Shaolin Capital Management
Florida
–
CAC
9
Cowen and Company
New York
–
Citadel Advisors
10
Citadel Advisors
Florida
–
Walleye Capital
11
Walleye Capital
New York
–
Walleye Trading
12
Walleye Trading
New York
–
CS
13
Clear Street
New York
–
UBS Group
14
UBS Group
Switzerland
–
HCM
15
Highbridge Capital Management
New York
–